Keywords: fda, extends, review, schering, yaz, nda, germany

FDA extends review of Schering's Yaz NDA

Article | 19 December 2005

Print This

Germany's Schering AG, says that the US Food and Drug Administration has informed its US affiliate, Berlex, that it is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in